astrazeneca.co.uk

AstraZeneca United Kingdom
Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that. AstraZeneca - a global research-based biopharmaceutical company
Slovakia; Spain; Sweden; Switzerland; United Kingdom; Middle East & North Africa. Turkey ... As a global biopharmaceutical company, AstraZeneca has a key contribution to make ... AstraZeneca - Wikipedia, the free encyclopedia
AstraZeneca plc (LSE: AZN, OMX: AZN) is a British -Swedish multinational pharmaceutical and biologics company headquartered in London, United Kingdom. It is the world ... AstraZeneca United Kingdom
We want to work with people who share our vision of creating new medicines and innovative approaches to healthcare that improve people’s lives. AstraZeneca $4bn approach for diabetes specialist Amylin - Telegraph
AstraZeneca $4bn approach for diabetes specialist Amylin AstraZeneca is understood to have made a $4bn (£2.6bn) takeover approach for Amylin, a US rival that ... AstraZeneca - UK court finds SEROQUEL XR® formulation patent invalid
UK court finds SEROQUEL XR® formulation patent invalid ... AstraZeneca today announced that the High Court in the UK has rendered its opinion on the formulation ... AstraZeneca Jobs - Find your perfect role at AstraZeneca and help ...
A note about work permits in the UK. AstraZeneca is an equal opportunity employer and we encourage diversity in the workplace. Current British and European Laws state that ... AstraZeneca braced for change under new chairman | Reuters
LONDON (Reuters) - AstraZeneca's new chairman took the helm on Friday and said the troubled drugmaker faced "a period of significant change". Leif ... AstraZeneca - Inspiring Careers
Sales Representatives sell AstraZeneca medicines to medical professionals such as doctors. The job involves a lot of travel, both in the UK and abroad. BBC News - AstraZeneca to cut a further 7,300 jobs
Anglo-Swedish drugs maker AstraZeneca has announced a further 7,300 job cuts over the next two years as part of a new restructuring programme. The GMB ...

AstraZeneca Buys Ardea Biosciences
AstraZeneca plc (AZN) recently announced that it has completed the acquisition of Ardea Biosciences, Inc. for approximately $1.26 billion or $32 per share. Both AstraZeneca and Ardea’s boards unanimously supported the merger. Ardea’s ... AstraZeneca, RIGL in Licensing Deal
AstraZeneca (AZN) and Rigel Pharmaceuticals, Inc. (RIGL) recently announced that they have entered into a licensing agreement for Rigel’s asthma candidate, R256. Per the terms of the agreement, AstraZeneca will make an upfront payment of $1 ... AstraZeneca, Rigel to Develop Asthma Treatment
AstraZeneca PLC (AZN, AZN.LN) has inked an agreement with Rigel Pharmaceuticals Inc. (RIGL) for the development and commercialization of an investigational asthma treatment. The treatment, R256, has been shown in preclinical studies to reduce ... AstraZeneca completes $1.26B Ardea purchase
NEW YORK — AstraZeneca PLC said Wednesday that it completed its $1.26 billion acquisition of gout drug developer Ardea Biosciences Inc. AstraZeneca agreed to buy Ardea in April for $32 per share, a 54 percent premium to the stock's closing ... GlaxoSmithKline and AstraZeneca launch pioneering approach to antibiotic research
It was announced today that GlaxoSmithKline and AstraZeneca have launched a pioneering approach to antibiotic research in Europe to attempt to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of ... AstraZeneca Buys Back 80,000 Own Shares to Cancel/2770P
AstraZeneca PLC (AZN.LN) said Monday it purchased for cancellation 80,000 of its own ordinary shares at a price of 2770 pence per share. -Shares at 0830 GMT down 23 pence, or 0.8%, at 2,748 pence valuing the company at GBP34.6 billion. AstraZeneca Ranks the Highest in Terms of Dividend Yield in the Pharmaceuticals Industry (AZN, LLY, NVS)
Dividends can enhance returns for investors seeking income in addition to capital gains. AstraZeneca (NYSE:AZN) is highest with a dividend yield of 9.0%. AstraZeneca PLC is a holding company. Through its subsidiaries, the Group researches, manufactures and ... UPDATE 3-Novartis, Astra win EU drug okays; Pfizer loses out
LONDON, June 22 (Reuters) - Novartis and AstraZeneca won recommendations for important new drugs from European regulators on Friday, while rival Pfizer lost out. The European Medicines Agency said its Committee for Medicinal Products for Human ... AstraZeneca Buys Back 484,970 Shares/2749P
LONDON--AstraZeneca PLC (>> AstraZeneca plc) said Tuesday that it purchased for cancellation 484,970 of its ordinary shares at 2749 pence per share on June 25. Shares at 0730 GMT down 6 pence, or 0.24%, at 2738.5 pence valuing the company at 34.6 billion pounds. AstraZeneca (AZN) Showing Bullish Technicals With Support At $42.54
Thursday, June 14, 2012... AstraZeneca (NYSE:AZN) closed Wednesday's downbeat trading session at $41.76. In the past year, the stock has hit a 52-week low of $39.72 and 52-week..... Friday, June 08, 2012... AstraZeneca Plc (NYSE: AZN) closed Thursday's ...